Immunization Newsbriefs (c) Copyright
Information Inc., Bethesda, MD. Brought to you by the National Network for
Immunization Information (NNii). Visit NNii's new website at
http://www.immunizationinfo.org.
MedImmune, a Gaithersburg, Md.-based
manufacturer, received a vote of support from a panel of Food and Drug
Administration advisors for its FluMist nasal spray influenza vaccine. The
panel determined that the vaccine was safe and effective for healthy people ages
five to 49. For individuals aged 50 to 64, the panel said that the vaccine is
safe, but some panel members said there is insufficient data to determine
FluMist's effectiveness in that age group. The panel's support of the vaccine
mean that the FDA will likely approve it for sale; the FDA generally follows the
recommendations of its panels.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.
"A foolish faith in authority is the worst enemy of truth."
-- Albert Einstein, letter to a friend, 1901
"I know of no safe depository of the ultimate powers of the society but the people themselves, and if we think them not enlightened enough to exercise control with a wholesome discretion, the remedy is not to take it from them, but to inform their discretion by education."
-- Thomas Jefferson, letter to William C. Jarvis, September 28, 1820
"What's the point of vaccination if it doesn't protect you from the unvaccinated?"
-- Sandy Gottstein
"Who gets to decide what the greater good is and how many will be sacrificed to it?"